These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14679275)

  • 61. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An analysis of the pediatric vaccine supply shortage problem.
    Jacobson SH; Sewell EC; Proano RA
    Health Care Manag Sci; 2006 Nov; 9(4):371-89. PubMed ID: 17186772
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Updated interim influenza vaccination recommendations--2004-05 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Dec; 53(50):1183-4. PubMed ID: 15614237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccine supply: a cross-national perspective.
    Danzon PM; Pereira NS; Tejwani SS
    Health Aff (Millwood); 2005; 24(3):706-17. PubMed ID: 15886165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jul; 49(27):619-22. PubMed ID: 10914929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):850. PubMed ID: 16138422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. U.S. vaccine and immune globulin product shortages, 2001-15.
    Ziesenitz VC; Mazer-Amirshahi M; Zocchi MS; Fox ER; May LS
    Am J Health Syst Pharm; 2017 Nov; 74(22):1879-1886. PubMed ID: 28970246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. US advisory panel urges government to subsidise vaccine costs. Recommendations would increase vaccination rates and stimulate research and development.
    Ault A
    Lancet; 2003 Aug; 362(9383):539. PubMed ID: 12932398
    [No Abstract]   [Full Text] [Related]  

  • 71. Availability of quality vaccines: the industrial point of view.
    Vandersmissen W
    Vaccine; 1992; 10(13):955-7. PubMed ID: 1471420
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emergency response vaccines--a challenge for the public sector and the vaccine industry.
    Milstien J; Lambert S
    Vaccine; 2002 Nov; 21(1-2):146-54. PubMed ID: 12443673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety.
    Nonzee NJ; Luu TH
    Cancer Treat Res; 2019; 171():75-92. PubMed ID: 30552658
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current status and future trends in vaccine regulation--USA.
    Falk LA; Ball LK
    Vaccine; 2001 Feb; 19(13-14):1567-72. PubMed ID: 11166876
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The vexing problems of vaccine compensation.
    Sun M
    Science; 1985 Mar; 227(4690):1012-4. PubMed ID: 3975597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The crisis in vaccine supply: a framework for action.
    Batson A; Evans P; Milstien JB
    Vaccine; 1994 Aug; 12(11):963-5. PubMed ID: 7975847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Federal polices affecting vaccine research and production.
    Riddiough MA; Willems JS
    Science; 1980 Aug; 209(4456):563-6. PubMed ID: 7394521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NVAC Statement of Support Regarding Efforts to Better Implement IIS-to-IIS Data Exchange Across Jurisdictions: Approved by the National Vaccine Advisory Committee on February 10, 2015.
    National Vaccine Advisory Committee
    Public Health Rep; 2015; 130(4):332-5. PubMed ID: 26346664
    [No Abstract]   [Full Text] [Related]  

  • 79. Key drivers behind the development of global vaccine market.
    Gréco M
    Vaccine; 2001 Feb; 19(13-14):1606-10. PubMed ID: 11166882
    [No Abstract]   [Full Text] [Related]  

  • 80. The current state of veterinary vaccines: is there hope for the future?
    Carter PB
    J Vet Med Educ; 2003; 30(2):152-4. PubMed ID: 12970862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.